SCHEMBL20129664

SCHEMBL20129664

CCOC(=O)c1cc(N(CC)C2CCN(c3ccccc3C#N)CC2C)c(C)cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 4/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
P2RY12 Q9H244 6/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.38
CHRM2 P08172 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
DRD3 P35462 1/20 0.38
MTOR P42345 2/20 0.37
RPTOR Q8N122 2/20 0.37
MLST8 Q9BVC4 2/20 0.37
GRM1 Q13255 1/20 0.37
ADAM17 P78536 2/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20129668 0.91 ADAM17 (0.39) ALDH1A1KDM4ECYP3A4DRD3MTOR
SCHEMBL20129671 0.89 ALDH1A1 (0.42) ALDH1A1KDM4EL3MBTL1LMNAHPGD
SCHEMBL20133653 0.87 P2RY12 (0.37) ALDH1A1KDM4EL3MBTL1LMNAHPGD
SCHEMBL22693207 0.86 L3MBTL1 (0.33) ALDH1A1KDM4EL3MBTL1LMNAP2RY12
SCHEMBL20149883 0.81 MTOR (0.45) ALDH1A1MTORRPTORMLST8GRM1
SCHEMBL20133654 0.81 MTOR (0.47) MTORRPTORMLST8GRM1ADAM17
SCHEMBL20129672 0.78 MTOR (0.42) ALDH1A1KDM4ELMNACYP3A4CYP2C9
SCHEMBL20133692 0.76 P2RY12 (0.39) ALDH1A1KDM4EL3MBTL1LMNAHPGD
SCHEMBL22693220 0.75 MTOR (0.46) MTORRPTORMLST8GRM1ADAM17
SCHEMBL20129630 0.75 MTOR (0.42) ALDH1A1KDM4ELMNAHPGDP2RY12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538091-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2019-09-18 EP disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR ALDH1A1 3942/4885KDM4E 253/4885L3MBTL1 3865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.